Vaginal microbiota and diverse pathogenic microorganisms

The vaginal microbiota is a dynamic ecosystem that plays a critical role in female reproductive health by maintaining a protective acidic environment, primarily through the production of lactic acid by Lactobacillus species (Ravel et al., 2011, PNAS). When this balance is disrupted, a state of dysbiosis occurs, characterized by the overgrowth of diverse pathogenic microorganisms including anaerobic bacteria (e.g., Gardnerella vaginalis), fungi (e.g., Candida albicans), and protozoa (e.g., Trichomonas vaginalis) (CDC, 2021). This shift is associated with clinical conditions such as bacterial vaginosis and increased risk for sexually transmitted infections and adverse pregnancy outcomes (NIH, 2023). Therapeutic interventions target this system either by directly eliminating pathogens with antimicrobial agents or by attempting to restore the commensal flora using probiotics (StatPearls, 2023). Managing the vaginal microbiota is essential for preventing pelvic inflammatory disease and improving overall gynecological health. Research into the vaginal microbiome also explores its role in the effectiveness of topical microbicides and the prevention of HIV transmission (PubMed, 2022). The complexity of these microbial interactions necessitates a multi-faceted approach to treatment that considers both the eradication of harmful species and the preservation of beneficial ones.

Other names

Vaginal microbiomeVaginal floraUrogenital microbiotaVaginal dysbiosis

Drugs targeting this system act by inhibiting bacterial DNA or protein synthesis, disrupting fungal cell membrane integrity, or restoring the dominance of beneficial Lactobacillus species to lower vaginal pH and inhibit pathogen growth.